Profund Advisors
PRME icon

Profund Advisors’s Prime Medicine PRME Stock Holding History

Profund Advisors’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$168K Sell
55,064
-17,560
-24% -$58.3K ﹤0.01% 1038
2026
Q2 		$268K Sell
72,624
-23,182
-24% -$77K 0.01% 881
2026
Q1 		$333K Buy
95,806
+26,201
+38% +$100K 0.01% 689
2025
Q4 		$242K Buy
+69,605
New +$310K 0.01% 1036
2023
Q4 		– Sell
-21,995
Closed -$210K – 1152
2023
Q3 		$210K Buy
+21,995
New +$286K 0.01% 868

Other funds holding PRME

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Alessandra Capital Management
Alessandra Capital Management Torrance, California $142M AUM 42.73% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Green Alpha Advisors
Green Alpha Advisors Niwot, Colorado $148M AUM 98.22% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $77B AUM 19.24% 1-Year Est. Return
Concurrent Investment Advisors
Concurrent Investment Advisors Tampa, Florida $14.5B AUM 24.52% 1-Year Est. Return
Pekin Hardy Strauss
Pekin Hardy Strauss Chicago, Illinois $1.14B AUM 25.53% 1-Year Est. Return
MAM
Milestone Asset Management Pittsburgh, Pennsylvania $631M AUM 19.95% 1-Year Est. Return
Oppenheimer & Co
Oppenheimer & Co New York $9.5B AUM 27.65% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return

Profund Advisors's PRME Position: Q3 2026 in Review

Profund Advisors reduced its Prime Medicine (PRME) stake by 24% in Q3 2026, selling an estimated $58.3K and leaving 55,064 shares worth $168K. The position accounts for ﹤0.01% of the portfolio, ranked #1038.

Profund Advisors first reported a position in PRME in Q3 2023 and has held it in 5 quarters since. The position peaked at $333K in Q1 2026. 46 funds tracked by Wall St. Rank hold PRME as of Q3 2026.

  • Profund Advisors held 55,064 shares of Prime Medicine worth $168K as of Q3 2026.
  • Profund Advisors sold 17,560 Prime Medicine shares in Q3 2026, an estimated $58.3K.
  • Prime Medicine made up ﹤0.01% of Profund Advisors's portfolio in Q3 2026, its #1038 holding.
  • Profund Advisors first reported a position in Prime Medicine in Q3 2023 and has held it in 5 quarters since.
  • Profund Advisors's Prime Medicine position peaked at $333K in Q1 2026.
  • 46 funds tracked by Wall St. Rank held Prime Medicine as of Q3 2026.

Based on Profund Advisors's 13F filing for Q3 2026, filed 29 Oct 2026.